California Governor Signed Bill Expanding PrEP Access
The new law mandates health insurers reimburse long-acting injectable HIV prevention through pharmacy benefits.
Updated on Sept. 29, 2026 in COVID-19
Live Poll
Should insurance companies be required to cover preventative medications through both medical and pharmacy benefits?
Governor Gavin Newsom has signed Senate Bill 1023, which requires health plans to cover injectable HIV pre-exposure prophylaxis (PrEP) through outpatient prescription drug benefits. This change aims to remove financial and administrative hurdles for smaller clinics by moving away from medical benefit billing.
Why it matters
Previously, providers faced significant administrative burdens and upfront costs because many health plans only reimbursed injectable PrEP through medical benefit pathways. This legislation simplifies the process for healthcare clinics to provide this vital HIV prevention medication.
Senate Bill 1023 mandates that health plans cover injectable PrEP through outpatient prescription drug benefits rather than medical benefit claims. This preventative treatment is typically administered once every six months.
The players
Gavin Newsom
He is the Governor of California who signed Senate Bill 1023 into law.
California Legislative LGBTQ Caucus
This group of state lawmakers identified the expansion of PrEP access as a legislative priority.
California Department of Insurance
This state agency acted as a co-sponsor of the legislation to streamline reimbursement processes.
The details
Under the new law, clinics no longer need to purchase expensive medication upfront or hire specialized staff to manage complex medical benefit claims. The legislation was a primary initiative of the California Legislative LGBTQ Caucus and received co-sponsorship from the California Department of Insurance.
Timeline
Jan. 1, 2027: The new law takes effect.
Health Landscape
This legislation builds upon the preventive care requirements established by the Affordable Care Act by addressing specific billing loopholes that hindered access to long-acting treatments. It reflects a broader shift toward integrating modern pharmaceutical innovations into standard health insurance reimbursement models.
Patients will find it easier to receive injectable PrEP at local community clinics without providers facing prohibitive administrative costs. This change helps ensure that HIV prevention remains accessible through standard pharmacy benefit pathways rather than restricted medical billing.
The takeaway
This law demonstrates how administrative reform can be as critical as medical innovation in improving public health outcomes. Readers should verify their own health plan coverage details for preventative treatments to understand how these legislative changes apply to their specific network.
Further reading
For more information on state public health policies, visit the California COVID-19 section.
More information
You can review the full text of the bill on the state legislative portal.
Source note: This article includes information reported by Paso Robles Daily News.
Live Poll
Should insurance companies be required to cover preventative medications through both medical and pharmacy benefits?
